FTXH vs PILL
First Trust Nasdaq Pharmaceuticals ETF against Direxion Daily Pharmaceutical & Medical Bull 3X ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
14%
14 shared positions
Fee gap
38 bp
FTXH is cheaper
1-year return gap
14.0 pts
PILL is ahead
Larger fund
FTXH
$1.1B
Side by side
| FTXH | PILL | |
|---|---|---|
| Fund | First Trust Nasdaq Pharmaceuticals ETF | Direxion Daily Pharmaceutical & Medical Bull 3X ETF |
| Issuer | First Trust | Direxion |
| Category | Health Care | Leveraged Equity |
| Expense ratio | 0.60% | 0.98% |
| Assets | $1.1B | $16M |
| Average daily dollar volume | $9.5M | $978K |
| Listed | Sep 20, 2016 | Nov 15, 2017 |
| FrenzyCap score | 50 | 33 |
| 1-month return | +0.8% | −2.7% |
| 3-month return | +3.3% | −35.2% |
| Year to date | +30.6% | +18.3% |
| 1-year return | +36.5% | +50.5% |
| 30-day volatility | 22.3% | 92.3% |
| Worst drawdown, 1 year | −7.5% | −43.8% |
| Trailing 12-month yield | 0.67% | 0.41% |
| Holdings | 51 | 67 |
| Top 10 weight | 56.7% | 253.2% |
| Look-through P/E | 48.1 | — |
| Holdings vs fair value | +8.6% | +18.4% |
| Holdings above 200-day average | 90% | 61% |
| Net flow, latest 3 reported months | +$3.3M thru Jun 2026 | +$914K thru Jul 2026 |
| 30-day implied volatility | 40.1% | 75.4% |
| Holdings as of | as of Nov 17, 2026issuer data | as of Nov 18, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
46% of FTXH · 17% of PILLSector mix of the stock holdings
| Sector | FTXH | PILL | Gap |
|---|---|---|---|
| Health Care | 97.7% | 56.8% | +40.9% |
| Technology | 2.0% | 0.0% | +2.0% |
More: full overlap table · FTXH holdings · PILL holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.